Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25.753
Filter
1.
Turk J Gastroenterol ; 35(5): 421-422, 2024 May.
Article in English | MEDLINE | ID: mdl-39128122

ABSTRACT

Cite this article as: Yüksekyayla O, Batibay E, Efe C. Unusual cause of gastrointestinal bleeding in an elderly adult: Gastric kissing ulcers. Turk J Gastroenterol. 2024;35(5):421-422.


Subject(s)
Gastrointestinal Hemorrhage , Stomach Ulcer , Humans , Stomach Ulcer/complications , Gastrointestinal Hemorrhage/etiology , Aged , Male , Female , Aged, 80 and over
2.
Khirurgiia (Mosk) ; (8): 21-25, 2024.
Article in Russian | MEDLINE | ID: mdl-39140939

ABSTRACT

OBJECTIVE: To improve the immediate postoperative results in patients with perforated ulcers. MATERIAL AND METHODS: The study enrolled 25 patients with perforated peptic ulcer (diameter of perforation <8 mm). Mean age of patients was 39 years (range 24-56), perforation size - 5.92 mm (range 3-8). RESULTS: Mean surgery time was 59.8 min (range 50-85). There were no intraoperative and postoperative complications. All patients were discharged. CONCLUSION: The proposed method of repair for perforated gastric ulcers is simple, effective, safe and may be recommended for clinical practice.


Subject(s)
Laparoscopy , Peptic Ulcer Perforation , Stomach Ulcer , Humans , Peptic Ulcer Perforation/surgery , Male , Female , Middle Aged , Laparoscopy/methods , Adult , Stomach Ulcer/surgery , Stomach Ulcer/complications , Treatment Outcome , Operative Time , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Outcome and Process Assessment, Health Care
3.
Nutrients ; 16(15)2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39125393

ABSTRACT

Phytochemicals found in fruits, vegetables, and plant-based foods have potential protective effects against various diseases, including gastric disorders. This study aimed to analyze the longitudinal association between phytochemical intake and the risk of gastritis/gastric ulcer in Korean adults. This was a prospective cohort study, a community-based cohort conducted as part of the Korean Genome and Epidemiology Study, examining the association between phytochemical intake and the risk of gastritis/gastric ulcer in Korean adults. Dietary information was collected using a validated semi-quantitative food frequency questionnaire, and the phytochemical index (PI) was calculated. The study included 7377 Korean men and women aged 40-69 years without gastritis/gastric ulcer at baseline of the Korea Association Resource study in Korea. The incidence of gastritis/gastric ulcer was determined using a survey questionnaire administered by trained staff. Multivariate Cox proportional hazards regression was used to calculate the hazard ratio and 95% confidence interval to determine the association between PI and risk of gastritis/gastric ulcer. During the median follow-up period of 9.50 years, 729 cases were reported. The fully adjusted model showed a significantly lower risk of gastritis/gastric ulcer in the highest PI quartile compared to the lowest (hazard ratio: 0.78, 95% confidence interval: 0.61-0.98), and this association was linear (p for trend = 0.01). This research indicates that incorporating foods abundant in phytochemicals into one's diet could be associated with a reduced risk of developing gastritis/gastric ulcers. These findings underscore the importance of further investigating the role of phytochemical-rich diets in gastrointestinal health, as demonstrated in this study.


Subject(s)
Diet , Gastritis , Phytochemicals , Stomach Ulcer , Humans , Middle Aged , Male , Female , Prospective Studies , Adult , Republic of Korea/epidemiology , Aged , Stomach Ulcer/epidemiology , Gastritis/epidemiology , Risk Factors , Diet/adverse effects , Incidence , Proportional Hazards Models , Fruit , Vegetables
4.
J Med Life ; 17(5): 523-529, 2024 May.
Article in English | MEDLINE | ID: mdl-39144695

ABSTRACT

Helicobacter pylori (HP) infection presents a significant threat to global health with serious associated morbidities. This study aimed to assess awareness, attitudes, and practices related to HP in the Kingdom of Saudi Arabia (KSA) through a survey-based cross-sectional study involving 2,541 respondents. We used a structured online questionnaire to gather data on personal and sociodemographic characteristics, as well as HP-related knowledge, attitudes, and practices. The survey was distributed through various social media platforms. The results revealed that 59.4% of respondents demonstrated good knowledge about HP, with a mean knowledge score of 3.7 ± 1.0 out of 5. Knowledge gaps were particularly evident regarding the contagiousness and transmission modes of HP. The mean attitude score was 12.2 ± 2.2 out of a maximum score of 15. In total, 37.6% of respondents reported ever being tested for HP, with 54.2% testing positive. Among those treated for HP, only 79% received antibiotic therapy and 37.8% received acid-reducing medications. Knowledge levels were significantly higher among younger and highly educated respondents (P < 0.001), and respondents with higher knowledge scores also had higher attitude scores than those with lower knowledge scores (12.6 ± 2.0 vs. 11.6 ± 2.0, P < 0.001). Individuals who had undergone HP testing had significantly higher knowledge levels than those who did not (62.3 vs. 57.8, P = 0.024). These findings underscore the urgent need for raising the population's awareness regarding the risks, prevention, and management of HP infection through targeted educational strategies.


Subject(s)
Health Knowledge, Attitudes, Practice , Helicobacter Infections , Helicobacter pylori , Stomach Ulcer , Humans , Saudi Arabia , Male , Female , Adult , Cross-Sectional Studies , Helicobacter Infections/drug therapy , Surveys and Questionnaires , Middle Aged , Stomach Ulcer/microbiology , Stomach Ulcer/drug therapy , Stomach Neoplasms/microbiology , Young Adult , Aged , Adolescent
5.
Zhongguo Zhong Yao Za Zhi ; 49(12): 3340-3347, 2024 Jun.
Article in Chinese | MEDLINE | ID: mdl-39041097

ABSTRACT

This study aims to explore the protective effect of Albizia chinensis saponin on ethanol-induced acute gastric ulcer in rats and elucidate its mechanisms. SD rats were deprived of water for 24 hours before the experiment. The control group and model group were administered water by gavage, and the positive drug group received rabeprazole sodium solution(40 mg·kg~(-1)) by gavage. The experimental groups were given different doses of Albizia chinensis saponin solution(3, 10, and 30 mg·kg~(-1)). After 30 minutes, the control group received 1.5 mL of water by gavage, while the other groups were administered an equal volume of 95% ethanol for modeling. After six hours, the rats were killed by cervical dislocation, and the stomachs were collected. The ulcer area was measured, and the ulcer index was calculated. Hematoxylin-eosin(HE) staining was performed to assess histopathological changes in gastric tissue. Periodic acid-Schiff(PAS) staining was used to evaluate the distribution of gastric mucosal surface mucus. Enzyme-linked immunosorbent assay(ELISA) was employed to measure the levels of phospholipids and aminohexose in the gastric mucosa. Western blot was performed to determine the expression levels of the bicarbonate transporter, matrix metalloproteinase, and tight junction-associated proteins in gastric tissue. Immunohistochemistry(IHC) staining was conducted to quantify the number of positive cells for secreted mucin and tight junction-associated proteins. The results showed that the gastric tissue surface of rats in the control group was smooth without ulceration, and the gastric ulcer index of rats in the model group was 35±11. Albizia chinensis saponin at doses of 3, 10, and 30 mg·kg~(-1) resulted in inhibition rates of gastric ulcer of 46%(P<0.01), 85%(P<0.001), and 100%(P<0.001), respectively. Severe disruption of gastric mucosal structure and absence of the mucus layer were observed in the model group. Compared with the model group, the Albizia chinensis saponin group showed intact gastric mucosal surface mucus layer, significantly increased levels of phospholipids and aminohexose in the mucus, increased number of MUC5AC positive cells, and upregulated expression levels of the bicarbonate transporter SLC26A3 and CFTR. It also showed decreased phosphorylation of JNK and c-Jun, reduced expression levels of MMP-8, elevated expression of TIMP-1, and increased expression levels of Occludin and ZO-1. In conclusion, Albizia chinensis saponin enhances the function of the mucus-bicarbonate barrier by upregulating the content of MUC5AC, phospholipids, and aminohexose and increasing the expression levels of the bicarbonate transporter SLC26A3 and CFTR. Moreover, Albizia chinensis saponin exerts its protective effects on gastric ulcers by inhibiting the JNK signaling pathway to prevent excessive activation of MMP-8, thereby reducing the degradation of Occludin and ZO-1 and enhancing the mucosal barrier function. In summary, Albizia chinensis saponin exerts its anti-gastric ulcer effects by simultaneously enhancing the mucus barrier and the mucosal barrier.


Subject(s)
Albizzia , Drugs, Chinese Herbal , Ethanol , Gastric Mucosa , Mucus , Rats, Sprague-Dawley , Saponins , Stomach Ulcer , Animals , Saponins/pharmacology , Rats , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Ethanol/adverse effects , Male , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism , Stomach Ulcer/prevention & control , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/pharmacology , Albizzia/chemistry , Mucus/metabolism , Protective Agents/pharmacology , Protective Agents/administration & dosage , Humans
6.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 40: e20240015, 2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39043471

ABSTRACT

OBJECTIVE: To evaluate synergistic antiulcer activity of ethanolic extracts of Tephrosia purpurea and Bacopa monnieri in ulcer induced rats. METHODS: Ethanolic leaf extracts of both the plants were administered individually and in combination at a dose of 200mg/kg to ulcer induced male albino rats. Omeprazole 10mg/kg was used as standard. Pylorus ligation method, ethanol and indomethacin induced gastric ulcer models were the different gastric ulcer models selected for the induction of ulcer in rats. Ulcer index, ulcer score, total acidity, pH, percentage protection, volume of gastric juice were the parameters evaluated and compared in different groups in all the models. RESULTS: Decrease in the ulcer score, ulcer index, total acidity was observed and percentage protection was significant(*p<0.05 and p<0.01) with the combination extract compared to group received individual plant extracts. CONCLUSION: Our results suggested that combination of two medicinal plants showed synergistic anti ulcer activity and decreased the formation of ulcer lesions in rats.


Subject(s)
Anti-Ulcer Agents , Bacopa , Drug Synergism , Plant Extracts , Plant Leaves , Stomach Ulcer , Tephrosia , Animals , Rats , Male , Plant Extracts/pharmacology , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Bacopa/chemistry , Plant Leaves/chemistry , Tephrosia/chemistry , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/isolation & purification , Ethanol , Rats, Sprague-Dawley
7.
Georgian Med News ; (349): 72-74, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38963205

ABSTRACT

Acid-related diseases (ARD) are the most common among digestive diseases. The main goals of therapy of ARD are to reduce the influence of aggression factors (production of HCl, pepsin) and increase the protective properties of the mucous membrane of the upper digestive tract. Also currently in medicine, one of the therapeutic and preventive methods is the use of chloride-hydrocarbonate sodium boron mineral waters. In this study, we compared the efficacy of table mineral waters in the therapy of induced gastropathy in Wistar rats. The study of the effect of mineral waters on the gastric mucosa of Wistar rats has provided valuable information that can be applied in medical practice for the treatment and prevention of various diseases of the gastrointestinal tract in humans. Careful analysis of the data obtained has shown that certain types of mineral waters can significantly reduce inflammatory processes and promote regeneration of the gastric mucosa, which makes them a useful addition to traditional treatment methods such as pharmacotherapy.


Subject(s)
Gastric Mucosa , Mineral Waters , Rats, Wistar , Animals , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Rats , Male , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/prevention & control
8.
Drug Res (Stuttg) ; 74(6): 280-289, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38968951

ABSTRACT

INTRODUCTION: Gastric ulcer is one of the most common and serious conditions in the gastrointestinal tract. One of the main causes of gastric ulcers is using of non-steroidal anti-inflammatory drugs (NSAIDs) which have limited their use in clinical practice. Several studies have revealed that metformin and Vitamin C (Vit C) exhibit protective effects against gastric mucosal damage in different animal models. However, no studies indicate their combination's effect on gastric ulcer models. Therefore, this study aims to investigate the protective effects of metformin and Vit C combination on indomethacin-induced gastric ulcers. MATERIAL AND METHODS: In total, thirty rats were divided into six groups, including the control group, rats received indomethacin (50 mg/kg, i.p.), rats received indomethacin and pretreated with ranitidine (100 mg/kg), metformin (100 mg/kg, i.p.), Vit C (100 mg/kg), or metformin combined with Vit C. Four hours after indomethacin administration, rats were euthanized, and gastric tissues were removed for macroscopic, histopathologic, and biochemical examinations. RESULTS: All therapeutics used in this study were found to alleviate gastric mucosal injury caused by indomethacin, as observed in histopathologic and macroscopic evaluations. Both Vit C and metformin were observed to significantly decrease lipid peroxidation and enhance the activity of anti-oxidative enzymes, SOD, GPx, and catalase. However, a more significant effectiveness was observed in catalase and GPx activities when Vit C was co-administered with metformin. CONCLUSIONS: In conclusion, the present study revealed that metformin and Vit C combination therapy could potentially treat gastric ulcers associated with indomethacin.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal , Ascorbic Acid , Gastric Mucosa , Indomethacin , Metformin , Stomach Ulcer , Animals , Metformin/pharmacology , Indomethacin/toxicity , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/pathology , Ascorbic Acid/pharmacology , Ascorbic Acid/therapeutic use , Rats , Male , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Gastric Mucosa/metabolism , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Lipid Peroxidation/drug effects , Antioxidants/pharmacology , Disease Models, Animal , Drug Therapy, Combination , Rats, Wistar , Anti-Ulcer Agents/pharmacology
9.
Langenbecks Arch Surg ; 409(1): 205, 2024 Jul 04.
Article in English | MEDLINE | ID: mdl-38963438

ABSTRACT

PURPOSE: This study aimed to evaluate the morbidity associated with excisional biopsy in patients with spontaneous gastric perforation. METHODS: A retrospective, single-center, observational study was performed. All consecutive patients with spontaneous gastric perforation who underwent surgical therapy were included. Outcomes were assessed concerning the performance of excisional biopsy. RESULTS: A total of 135 adult patients were enrolled. Of these, 110 (81.5%) patients underwent excisional biopsy, while 17 (12.6%) did not. The remaining eight (5.9%) patients who underwent gastric resection were excluded from the analysis. Patients undergoing excisional biopsy developed significantly higher rates of postoperative complications (p = 0.007) and experienced more severe complications according to the Clavien-Dindo classification, particularly type III and above (p = 0.017). However, no significant differences were observed regarding in-hospital mortality, reoperation, suture dehiscence, or length of hospital stay. CONCLUSION: Excisional biopsy for gastric perforation has been shown to be associated with increased morbidity. Surgical closure followed by early endoscopic biopsy may be a superior approach for gastric perforation management to rule out malignancy.


Subject(s)
Peptic Ulcer Perforation , Stomach Ulcer , Humans , Male , Female , Retrospective Studies , Middle Aged , Aged , Stomach Ulcer/pathology , Stomach Ulcer/surgery , Peptic Ulcer Perforation/surgery , Peptic Ulcer Perforation/pathology , Peptic Ulcer Perforation/mortality , Biopsy , Adult , Postoperative Complications/etiology , Aged, 80 and over
10.
Sci Rep ; 14(1): 17390, 2024 07 29.
Article in English | MEDLINE | ID: mdl-39075113

ABSTRACT

We evaluate the value of oral contrast-enhanced gastric ultrasonography (OCUS) by comparing it with conventional gastroscopy in diagnosing and staging benign peptic ulcer. From July 2018 to December 2020, 44 patients with gastroscopy-confirmed benign peptic ulcers (a total of 45 ulcers were detected), who also received OCUS, were retrospectively reviewed. Each patient's ultrasound images were compared with gastroscopy and pathology findings. The characteristics of ultrasonic images of different stages of ulcer were analysed. A total of 43 ulcers were detected by OCUS in 44 patients with benign peptic ulcers. There were no false positive results among the OCUS exams, but two ulcers were misdiagnosed. OCUS for benign peptic ulcer staging also shows acceptable clinical practice results. OCUS is useful for detecting and staging benign peptic ulcer, and may be considered an alternative method for conventional gastroscopy. OCUS is especially useful in the follow-up of BPU treatment, but futher study is needed to improve the diagnostic accuracy of benign and malignant ulcers.


Subject(s)
Contrast Media , Peptic Ulcer , Ultrasonography , Humans , Male , Female , Ultrasonography/methods , Middle Aged , Peptic Ulcer/diagnostic imaging , Peptic Ulcer/pathology , Aged , Adult , Retrospective Studies , Gastroscopy/methods , Stomach/diagnostic imaging , Stomach/pathology , Aged, 80 and over , Stomach Ulcer/diagnostic imaging , Stomach Ulcer/pathology
11.
Nutrients ; 16(14)2024 Jul 17.
Article in English | MEDLINE | ID: mdl-39064740

ABSTRACT

Anisomeles indica (L.) Kuntze is a traditional herb with multiple medicinal properties and with potential for preventing or treating various diseases. Acteoside, one of the active ingredients in A. indica, is prepared into commercially available products of A. indica HP813 powder. In this study, the gastroprotective effects of A. indica HP813 powder were evaluated. Wistar rats were treated with A. indica HP813 powder at doses of 0, 207.5, 415, and 830 mg/kg body weight for 28 days. Then, gastric ulcers were induced by the oral administration of 70% ethanol (10 mL/kg body weight) on day 28. The rats were sacrificed at the end of the trial, and stomach tissues were collected. These stomach tissues were then used for macroscopic, microscopic, and immunohistochemical analyses. The results indicated that the area of gastric ulcer was 48.61%, 35.30%, and 27.16% in the ethanol-induced group, 415 mg/kg A. indica HP813 powder group, and 830 mg/kg A. indica HP813 powder group, respectively. In addition, the lesion scores were 2.9, 2.4, and 2.3 in the ethanol-induced group, 415 mg/kg A. indica HP813 powder group, and 830 mg/kg A. indica HP813 powder group, respectively. The immunochemical staining of the gastric tissue revealed that A. indica HP813 powder reduced the expressions of TNF-α and NF-κB proteins in the gastric tissue, which had been induced by ethanol. Finally, A. indica HP813 powder protected the gastric ulcer from ethanol damage through IκB-α induction. The present results demonstrated that A. indica HP813 powder has protective effects against ethanol-induced gastric ulcer.


Subject(s)
Anti-Ulcer Agents , Ethanol , NF-KappaB Inhibitor alpha , NF-kappa B , Stomach Ulcer , Animals , Male , Rats , Anti-Ulcer Agents/pharmacology , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , NF-kappa B/metabolism , NF-KappaB Inhibitor alpha/metabolism , Plant Extracts/pharmacology , Powders , Rats, Wistar , Stomach Ulcer/chemically induced , Stomach Ulcer/prevention & control , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism
12.
World J Gastroenterol ; 30(24): 3076-3085, 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38983956

ABSTRACT

BACKGROUND: Helicobacter pylori (H. pylori) infection is closely associated with gastrointestinal diseases. Our preliminary studies have indicated that H. pylori infection had a significant impact on the mucosal microbiome structure in patients with gastric ulcer (GU) or duodenal ulcer (DU). AIM: To investigate the contributions of H. pylori infection and the mucosal microbiome to the pathogenesis and progression of ulcerative diseases. METHODS: Patients with H. pylori infection and either GU or DU, and healthy individuals without H. pylori infection were included. Gastric or duodenal mucosal samples was obtained and subjected to metagenomic sequencing. The compositions of the microbial communities and their metabolic functions in the mucosal tissues were analyzed. RESULTS: Compared with that in the healthy individuals, the gastric mucosal microbiota in the H. pylori-positive patients with GU was dominated by H. pylori, with significantly reduced biodiversity. The intergroup differential functions, which were enriched in the H. pylori-positive GU patients, were all derived from H. pylori, particularly those concerning transfer RNA queuosine-modification and the synthesis of demethylmenaquinones or menaquinones. A significant enrichment of the uibE gene was detected in the synthesis pathway. There was no significant difference in microbial diversity between the H. pylori-positive DU patients and healthy controls. CONCLUSION: H. pylori infection significantly alters the gastric microbiota structure, diversity, and biological functions, which may be important contributing factors for GU.


Subject(s)
Duodenal Ulcer , Gastric Mucosa , Gastrointestinal Microbiome , Helicobacter Infections , Helicobacter pylori , Stomach Ulcer , Humans , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Helicobacter pylori/genetics , Duodenal Ulcer/microbiology , Duodenal Ulcer/diagnosis , Male , Female , Middle Aged , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Stomach Ulcer/microbiology , Adult , Case-Control Studies , Aged , Metagenomics/methods , Duodenum/microbiology , Dysbiosis/microbiology
13.
Res Vet Sci ; 176: 105346, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38968646

ABSTRACT

Equine gastric ulcer syndrome (EGUS) is a prevalent condition in horses, affecting up to 93% of racehorses. Comprising the equine squamous gastric disease (ESGD) and the equine glandular gastric disease (EGGD), EGUS poses significant health challenges. Saliva, a non-invasive and easily obtainable sample, is increasingly recognized for its potential as a source of biomarkers in horses. This study investigates changes in saliva analytes using automated assays before and after EGUS treatment, aiming to identify biomarkers indicative of treatment success or failure. A total of 28 horses diagnosed with EGUS were treatment with omeprazole for six weeks and further divided into successful (n = 15) or unsuccessful (n = 13) treatment group. Saliva samples were collected before and after treatment, and analytes related to enzymes, metabolites, proteins, redox biomarkers, and minerals were measured using an automated chemistry analyzer. Results revealed that horses with successful treatment, indicated by reduced EGGD and ESGD scores, showed significant increases in bicarbonate and urea, and decreases in adenosine deaminase (ADA), and creatine kinase (CK). Conversely, horses with non-successful treatment showed no significant changes in salivary analytes. These analytes have the advantages of an easy and fast measurement and the possibility of being applied in routine. Further studies with larger populations should be performed to establish the possible practical application of these analytes as biomarkers of treatment.


Subject(s)
Biomarkers , Horse Diseases , Omeprazole , Saliva , Stomach Ulcer , Animals , Horses , Horse Diseases/metabolism , Saliva/chemistry , Stomach Ulcer/veterinary , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism , Pilot Projects , Omeprazole/therapeutic use , Female , Biomarkers/analysis , Biomarkers/metabolism , Male , Anti-Ulcer Agents/therapeutic use
14.
Drugs ; 84(7): 863-866, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38916840

ABSTRACT

Zastaprazan (JAQBO®) is a next-generation potassium-competitive acid blocker being developed by Onconic Therapeutics, a subsidiary of Jeil Pharmaceutical, for the treatment of acid-related diseases. Zastaprazan binds directly to proton pumps in a competitive manner to reduce gastric acid secretion, allowing for a quick onset of action. On 24 April 2024, zastaprazan received approval in South Korea for the treatment of erosive gastroesophageal reflux disease (GERD). Zastaprazan is also undergoing phase III development for the treatment of gastric ulcer and for the prevention of non-steroidal anti-inflammatory drug (NSAID)-induced peptic ulcer. This article summarizes the milestones in the development of zastaprazan leading to this first approval for erosive GERD.


Subject(s)
Drug Approval , Gastroesophageal Reflux , Proton Pump Inhibitors , Pyrroles , Sulfonamides , Humans , Gastroesophageal Reflux/drug therapy , Proton Pump Inhibitors/pharmacology , Proton Pump Inhibitors/adverse effects , Proton Pump Inhibitors/therapeutic use , Sulfonamides/pharmacology , Sulfonamides/therapeutic use , Pyrroles/pharmacology , Pyrroles/therapeutic use , Pyrroles/adverse effects , Republic of Korea , Peptic Ulcer/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Stomach Ulcer/drug therapy , Stomach Ulcer/chemically induced
15.
Int Immunopharmacol ; 137: 112440, 2024 Aug 20.
Article in English | MEDLINE | ID: mdl-38870882

ABSTRACT

Yucca filamentosa (YF) is widely used in folk medicine for its anti-inflammatory effects. Our study aimed to evaluate the chemical profile of YF extracts. Additionally, the gastroprotective efficacy of its crude leaf extract and nano-cubosomal formulation was assessed in a rat model of ethanol-induced gastric injury by altering the HMGB-1/RAGE/TLR4/NF-κB pathway. The phytochemical composition of YF was investigated using FTIR spectroscopy and LC-MS/MS techniques. Standardization was further accomplished using HPLC. Rats were treated orally with yucca crude extract or its nano-cubosomal formulation at doses of 25, 50, and 100 mg/kg. Famotidine (50 mg/kg, IP) was used as a reference drug. After 1 h, rats were administered ethanol (1 ml, 95 %, orally). One hour later, the rats were sacrificed, and the serum was separated to determine TNF-α and IL-6 levels. Stomachs were excised for the calculation of the ulcer index and histopathological examinations. Stomach tissue homogenate was used to determine MDA and catalase levels. Additionally, the expression levels of HMGB-1/RAGE/TLR4/NF-κB were assessed. Phytochemical analysis confirmed the predominance of steroidal saponins, sucrose, organic and phenolic acids, and kaempferol. The nano-cubosomal formulation demonstrated enhanced gastroprotective, anti-oxidant, and anti-inflammatory efficacy compared to the crude extract at all tested doses. The most prominent effect was observed in rats pretreated with the YF nano-cubosomal formulation at a dose of 100 mg/kg, which was similar to normal control and famotidine-treated rats. Our results highlighted the enhanced gastroprotective impact of the yucca nano-cubosomal formulation in a dose-dependent manner. This suggests its potential use in preventing peptic ulcer recurrence.


Subject(s)
Anti-Ulcer Agents , Ethanol , HMGB1 Protein , Plant Extracts , Plant Leaves , Stomach Ulcer , Yucca , Animals , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Ethanol/chemistry , Plant Leaves/chemistry , Male , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/pathology , HMGB1 Protein/metabolism , Rats , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/therapeutic use , Anti-Ulcer Agents/chemistry , Anti-Ulcer Agents/administration & dosage , Yucca/chemistry , NF-kappa B/metabolism , Toll-Like Receptor 4/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Rats, Wistar , Nanoparticles/chemistry , Interleukin-6/metabolism , Interleukin-6/blood , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/blood
16.
J Mol Histol ; 55(4): 567-579, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38888815

ABSTRACT

Clinopodium menthifolium (wood calamint) is a folkloric medicinal plant ingested as a treatment for many human disorders including gastric disorders. Our study evaluates the anti-ulcer potentials of Clinopodium menthifolium ethanol extracts (CMEE) in induced gastric ulcers in rats. Thirty Dawley male rats were divided into 5 groups: normal and ulcer controls, treated orally with Tween 20%; reference rats treated with Omeprazole 20 mg/kg, and the remaining two groups received 250 and 500 mg/kg CMEE for 2 weeks. After that, food was taken away for 24 h, and then, rats received ethanol-induced gastric ulceration (except normal control), 80% (1 ml/rat). After anesthetization and sacrificing, the ulcer index, mucus content, and other ulcer measurements were obtained from dissected rat stomachs. Stomach tissues were also analyzed by different histology procedures and homogenized stomach tissues were assessed for their antioxidant contents. The toxicity trial showed the absence of any toxic signs in rats supplemented with 2 and 5 g/kg of CMEE. The gastroprotective results showed a significantly lower ulcer index and higher gastric mucin content in CMEE-ingested rats compared to ulcer controls. Furthermore, CMEE treatments significantly increased the intensity of periodic acid Schiff stained (PAS), HSP 70 protein, and down-regulation of Bax protein expression in the stomach epithelium. Rats supplemented with 500 mg/kg revealed noticeable changes in their serum inflammatory cytokines along with positive regulations of antioxidant enzymes. The outcomes provide a scientific backup behind the gastroprotective potential effect of CMEE that could serve as a natural resource against peptic ulcers.


Subject(s)
Ethanol , Plant Extracts , Stomach Ulcer , bcl-2-Associated X Protein , Animals , Ethanol/adverse effects , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism , Stomach Ulcer/pathology , Rats , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Male , bcl-2-Associated X Protein/metabolism , Rats, Sprague-Dawley , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Gastric Mucosa/metabolism , Inflammation/drug therapy , Inflammation/pathology , Inflammation/metabolism , Heat-Shock Proteins/metabolism , Antioxidants/pharmacology , Stomach/pathology , Stomach/drug effects , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/therapeutic use , HSP70 Heat-Shock Proteins/metabolism
17.
Bioorg Chem ; 150: 107577, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38941697

ABSTRACT

Aiming to discover effective and safe non-steroidal anti-inflammatory agents, a new set of 1,2,4-triazole tetrahydroisoquinoline hybrids 9a-g, 11a-g and 12a-g was synthesized and evaluated as inhibitors of COX-1 and COX-2. In order to overcome the adverse effects of highly selective COX-2 and non-selective COX-2 inhibitors, the compounds of this study were designed with the goal of obtaining moderately selective COX-2 inhibitors. In this study compounds 9e, 9g and 11f are the most effective derivatives against COX-2 with IC50 values 0.87, 1.27 and 0.58 µM, respectively which are better than or comparable to the standard drug celecoxib (IC50 = 0.82 µM) but with lower selectivity indices as required by our goal design. The results of the in vivo anti-inflammatory inhibition test revealed that compounds 9e, 9g and 11f displayed a higher significant anti-inflammatory activity than celecoxib at all-time intervals. In addition, these compounds significantly decreased the production of inflammatory mediators PGE-2, TNF-ɑ and IL-6. Compounds 9e, 9g and 11f had a safe gastric profile compared to indomethacin, also compound 11f (ulcerogenic index = 1.33) was less ulcerous than the safe celecoxib (ulcerogenic index = 3). Moreover, histopathological investigations revealed a normal architecture of both paw skin and gastric mucosa after oral treatment of rats with compound 11f. Furthermore, molecular docking studies were performed on COX-1 and COX-2 to study the binding pattern of compounds 9e, 9g and 11f on both isoenzymes.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal , Cyclooxygenase 1 , Cyclooxygenase 2 , Drug Design , Edema , Triazoles , Triazoles/chemistry , Triazoles/pharmacology , Triazoles/chemical synthesis , Animals , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Structure-Activity Relationship , Rats , Edema/drug therapy , Edema/chemically induced , Molecular Structure , Tetrahydroisoquinolines/pharmacology , Tetrahydroisoquinolines/chemistry , Tetrahydroisoquinolines/chemical synthesis , Cyclooxygenase Inhibitors/pharmacology , Cyclooxygenase Inhibitors/chemical synthesis , Cyclooxygenase Inhibitors/chemistry , Dose-Response Relationship, Drug , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2 Inhibitors/chemical synthesis , Cyclooxygenase 2 Inhibitors/chemistry , Molecular Docking Simulation , Male , Carrageenan , Rats, Wistar , Humans , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy
18.
Fitoterapia ; 177: 106072, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38897249

ABSTRACT

E. tournefortii has wound healing properties in folk medicine and 5% infusions are used for stomach ulcers. It is also used in colds, abdominal pain, digestive problems, as an appetite enhancer and antispasmodic. For this purpose, in the study biochemical and histopathological evaluation of the ulcer protective effect of the extract obtained from the E. tournefortii in the indomethacin-induced gastric ulcer model in rats was aimed to develop new strategies in the treatment of ulcers. The phytochemical profile of the plant was elucidated for the first time by LC-HRMS in this study. The results indicate that, in terms of TNF-α, IL-1ß, IL-8, IL-6, PGE2, NF-κB, VEGF, NO, COX-1 and COX-2 biochemical parameters, E. tournefortii protects the gastric mucosa to the inflammation, and also modulates the PGE2 pathway, and has a similar effect or even a more positive effect than the reference substance lansoprazole. According to LC-HRMS analysis results, chlorogenic acid, genistein and quinic acid were the main constituents of E. tournefortii extract with 1397.081, 1014.177 and 992.527µg/g extract, respectively. Considering the anti-inflammatory and antioxidant effects of these phenolic components, it is thought that the major components are responsible for the anti-ulcer activity of the E. tournefortii extract.


Subject(s)
Anti-Ulcer Agents , Indomethacin , Phytochemicals , Plant Extracts , Stomach Ulcer , Animals , Rats , Phytochemicals/pharmacology , Phytochemicals/isolation & purification , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Male , Plant Extracts/pharmacology , Plant Extracts/chemistry , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/isolation & purification , Rats, Wistar , Gastric Mucosa/drug effects , Dinoprostone/metabolism , Molecular Structure
19.
J Agric Food Chem ; 72(25): 14165-14176, 2024 Jun 26.
Article in English | MEDLINE | ID: mdl-38872428

ABSTRACT

Atractylodes macrocephala Koidz, a traditional Chinese medicine, contains atractylenolide I (ATR-I), which has potential anticancer, anti-inflammatory, and immune-modulating properties. This study evaluated the therapeutic potential of ATR-I for indomethacin (IND)-induced gastric mucosal lesions and its underlying mechanisms. Noticeable improvements were observed in the histological morphology and ultrastructures of the rat gastric mucosa after ATR-I treatment. There was improved blood flow, a significant decrease in the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1ß, and IL-18, and a marked increase in prostaglandin E2 (PGE2) expression in ATR-I-treated rats. Furthermore, there was a significant decrease in the mRNA and protein expression levels of NOD-like receptor thermal protein domain associated protein 3 (NLRP3), apoptosis-associated speck-like protein (ASC), cysteinyl aspartate specific proteinase-1 (caspase-1), and nuclear factor-κB (NF-κB) in rats treated with ATR-I. The results show that ATR-I inhibits the NLRP3 inflammasome signaling pathway and effectively alleviates local inflammation, thereby improving the therapeutic outcomes against IND-induced gastric ulcers in rats.


Subject(s)
Atractylodes , Gastric Mucosa , Indomethacin , Inflammasomes , Lactones , NLR Family, Pyrin Domain-Containing 3 Protein , Rats, Sprague-Dawley , Sesquiterpenes , Stomach Ulcer , Animals , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , Indomethacin/adverse effects , Stomach Ulcer/drug therapy , Stomach Ulcer/chemically induced , Stomach Ulcer/metabolism , Rats , Sesquiterpenes/pharmacology , Sesquiterpenes/chemistry , Lactones/pharmacology , Lactones/chemistry , Inflammasomes/metabolism , Inflammasomes/genetics , Inflammasomes/drug effects , Male , Atractylodes/chemistry , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Humans , NF-kappa B/genetics , NF-kappa B/metabolism , NF-kappa B/immunology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/immunology , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Interleukin-1beta/immunology , Caspase 1/genetics , Caspase 1/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Interleukin-6/immunology , Interleukin-18/genetics , Interleukin-18/metabolism
20.
Mol Biol Rep ; 51(1): 744, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38874632

ABSTRACT

BACKGROUND: Vanillic acid (VA; 4-hydroxy-3-methoxybenzoic acid) is a flavouring agent found in various natural sources such as olives, fruits, and green tea. While VA exhibits numerous pharmacological effects, its potential protective effects against gastric injury warrants further investigation. Therefore, the primary objective of this study is to elucidate investigate the gastroprotective properties of VA against ethanol-induced gastric injury. METHODS AND RESULTS: Rats were orally administered either saline or VA at different doses (50, 100, and 200 mg/kg/day), with omeprazole (20 mg/kg) serving as a positive control, for fourteen consecutive days before ethanol administration. Blood and gastric tissue samples were collected one hour after ethanol administration for biochemical, molecular, and histological analyses. Pre-treatment with VA before ulcer induction alleviated both macroscopic and microscopic damage. It also increased antioxidant glutathione levels and decreased malondialdehyde and myeloperoxidase activity, along with reducing inflammatory markers such as tumour necrosis factor (TNF)-α, interleukin (IL)-6, and nuclear factor kappa B (NF-κB). Additionally, VA pre-treatment reversed the elevation of Bax mRNA expression and gastric caspase-3 levels induced by gastric damage. It also mitigated the reduction in Bcl-2 mRNA expression. CONCLUSION: These findings suggest that VA exerts protective effects against ethanol-induced gastric injury in rats. It achieves this by augmenting gastric antioxidant capacity and mitigating oxidative, inflammatory, and apoptotic damage.


Subject(s)
Apoptosis , Ethanol , NF-kappa B , Signal Transduction , Stomach Ulcer , Vanillic Acid , Animals , NF-kappa B/metabolism , Ethanol/toxicity , Ethanol/adverse effects , Rats , Apoptosis/drug effects , Vanillic Acid/pharmacology , Signal Transduction/drug effects , Male , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism , Stomach Ulcer/pathology , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Gastric Mucosa/metabolism , Gastric Mucosa/injuries , Oxidative Stress/drug effects , Antioxidants/pharmacology , Antioxidants/metabolism , Protective Agents/pharmacology , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/genetics , Glutathione/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL